ResMed Inc.

XNYSHealth care

Last traded price · USD

$228.84

+0.78%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 14:52 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $227.08
Volume: 2,126
Day's high: —
Day's low: —

In brief

ResMed Inc. is a health care company listed on the New York Stock Exchange, valued at about $32.19B.
Its shares closed at $227.08 on 3 Nov 2026, down 8.8% over the past year.
From India you can buy RMD in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy ResMed Inc. (RMD) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole RMD share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade RMD options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

12.3 days to cover short interest
11.9M shares were sold short at the 15 Oct 2026 settlement, 8.5% of the 140.7M shares outstanding; covering them would take 12.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +1.9% (SPY −2.6%, XLV +9.9%). 3 months: +1.8% (SPY −2.2%, XLV +13.5%). 1 year: −8.8% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: RMD, SPY and XLV · as of 3 Nov 2026
Below its 50-day average, above its 200-day
The 3 Nov 2026 close of $227.08 was 2.0% below its 50-day average ($231.72) and 1.1% above its 200-day average ($224.59). It has closed above the 200-day for 20 sessions, since 7 Oct 2026. The 50-day average crossed above the 200-day on 12 Oct 2026, 16 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
Volume 1.8× its 30-session average on 3 Nov 2026
3 Nov 2026 volume of 2.2M shares was 1.8× the average of the 30 sessions before it (1.2M), as the price fell 2.5%. SPY traded 0.8× its own average that session.
Daily volume against a 30-session baseline · as of 3 Nov 2026
Next ex-dividend date: 12 Nov 2026
$0.66 a share, payable 17 Dec 2026; unchanged from the previous payment (ex-date 20 Aug 2026).
Corporate actions record · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month+1.9%

6 months+9.2%

1 year−8.8%

5 years−15.3%

Newswire

About

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.

Website

Notable moves

June 24, 2024
−11.48%
April 26, 2024
+18.89%
August 4, 2023
−18.50%

ResMed Inc.

XNYSHealth care

Last traded price · USD

$228.84

+0.78%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 14:52 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $227.08
Volume: 2,126
Day's high: —
Day's low: —

In brief

ResMed Inc. is a health care company listed on the New York Stock Exchange, valued at about $32.19B.
Its shares closed at $227.08 on 3 Nov 2026, down 8.8% over the past year.
From India you can buy RMD in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy ResMed Inc. (RMD) shares from India?

Do I need the price of a whole RMD share to invest?

How much can I invest in US stocks in a year?

Can I trade RMD options or futures?

Insights

Quotes run fifteen minutes behind.

12.3 days to cover short interest
11.9M shares were sold short at the 15 Oct 2026 settlement, 8.5% of the 140.7M shares outstanding; covering them would take 12.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +1.9% (SPY −2.6%, XLV +9.9%). 3 months: +1.8% (SPY −2.2%, XLV +13.5%). 1 year: −8.8% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: RMD, SPY and XLV · as of 3 Nov 2026
Below its 50-day average, above its 200-day
The 3 Nov 2026 close of $227.08 was 2.0% below its 50-day average ($231.72) and 1.1% above its 200-day average ($224.59). It has closed above the 200-day for 20 sessions, since 7 Oct 2026. The 50-day average crossed above the 200-day on 12 Oct 2026, 16 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
Volume 1.8× its 30-session average on 3 Nov 2026
3 Nov 2026 volume of 2.2M shares was 1.8× the average of the 30 sessions before it (1.2M), as the price fell 2.5%. SPY traded 0.8× its own average that session.
Daily volume against a 30-session baseline · as of 3 Nov 2026
Next ex-dividend date: 12 Nov 2026
$0.66 a share, payable 17 Dec 2026; unchanged from the previous payment (ex-date 20 Aug 2026).
Corporate actions record · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month+1.9%

6 months+9.2%

1 year−8.8%

5 years−15.3%

Newswire

About

Website

Notable moves

June 24, 2024
−11.48%
April 26, 2024
+18.89%
August 4, 2023
−18.50%

ResMed Inc.

ResMed Inc. in brief

12.3 days to cover short interest

Behind SPY and its sector fund XLV over 1 year

Below its 50-day average, above its 200-day

Volume 1.8× its 30-session average on 3 Nov 2026

Next ex-dividend date: 12 Nov 2026

ResMed Inc.

ResMed Inc. in brief

12.3 days to cover short interest

Behind SPY and its sector fund XLV over 1 year

Below its 50-day average, above its 200-day

Volume 1.8× its 30-session average on 3 Nov 2026

Next ex-dividend date: 12 Nov 2026